1. Home
  2. AKTX vs INKT Comparison

AKTX vs INKT Comparison

Compare AKTX & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AKTX
  • INKT
  • Stock Information
  • Founded
  • AKTX N/A
  • INKT 2017
  • Country
  • AKTX United States
  • INKT United States
  • Employees
  • AKTX N/A
  • INKT N/A
  • Industry
  • AKTX Biotechnology: Pharmaceutical Preparations
  • INKT Medicinal Chemicals and Botanical Products
  • Sector
  • AKTX Health Care
  • INKT Health Care
  • Exchange
  • AKTX Nasdaq
  • INKT Nasdaq
  • Market Cap
  • AKTX 24.5M
  • INKT 33.6M
  • IPO Year
  • AKTX N/A
  • INKT 2021
  • Fundamental
  • Price
  • AKTX $1.13
  • INKT $8.79
  • Analyst Decision
  • AKTX
  • INKT Strong Buy
  • Analyst Count
  • AKTX 0
  • INKT 2
  • Target Price
  • AKTX N/A
  • INKT $37.50
  • AVG Volume (30 Days)
  • AKTX 28.3K
  • INKT 9.1K
  • Earning Date
  • AKTX 05-15-2025
  • INKT 03-18-2025
  • Dividend Yield
  • AKTX N/A
  • INKT N/A
  • EPS Growth
  • AKTX N/A
  • INKT N/A
  • EPS
  • AKTX N/A
  • INKT N/A
  • Revenue
  • AKTX N/A
  • INKT N/A
  • Revenue This Year
  • AKTX N/A
  • INKT N/A
  • Revenue Next Year
  • AKTX N/A
  • INKT N/A
  • P/E Ratio
  • AKTX N/A
  • INKT N/A
  • Revenue Growth
  • AKTX N/A
  • INKT N/A
  • 52 Week Low
  • AKTX $0.85
  • INKT $4.56
  • 52 Week High
  • AKTX $4.40
  • INKT $19.00
  • Technical
  • Relative Strength Index (RSI)
  • AKTX 55.37
  • INKT 50.92
  • Support Level
  • AKTX $1.24
  • INKT $8.60
  • Resistance Level
  • AKTX $1.56
  • INKT $9.23
  • Average True Range (ATR)
  • AKTX 0.12
  • INKT 0.85
  • MACD
  • AKTX 0.01
  • INKT 0.08
  • Stochastic Oscillator
  • AKTX 45.26
  • INKT 52.83

About AKTX Akari Therapeutics plc ADS

Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).

About INKT MiNK Therapeutics Inc.

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.

Share on Social Networks: